Definition
- General: coughing of blood from pulmonary parenchyma or tracheobronchial tree
- Massive: arbitrary quantity: 100-600ml/24hr <5% patients have massive bleeding
Etiology
- Ascertain source is pulmonary
- Common causes: (differ in regular vs. massive)
- chronic bronchitis
- bronchiectasis
- bronchogenic carcinoma (50% present with minor hemoptysis)
- TB (historically #1)
- fungal disease
- bacterial pneumonia
- lung abscess (15% cases hemoptysis)
- pulmonary infarct
- cryptogenic (0.8-15%)
- less common: mitral stenosis, Goodpasture's, endobronchial foreign body,
bronchial adenoma, pulmonary AV fistula, coagulopathy
- Must suspect bronchogenic carcinoma in >40 yo smoker
- May result from metastatic carcinoma, typically breast, colon, or malignant
melanoma
Pathophysiology
- dual circulation
- usually from bronchial arteries and collaterals from axillary, intercostal,
diaphragmatic and systemic arteries of thorax
- 10% cases bleed from pulmonary arteries, capillaries or veins
- vascular mechanisms
- aneurysm formation
- vasculitis
- pulmonary embolism
- inflammation
- broncholithiasis
- direct invasion central pulmonary artery trauma
Diagnosis
- Physical examination
- confirm source
- which hemithorax
- localized rales, rhonchi, or wheezing
- Chest Radiography
- confluent or patchy alveolar filling pattern
- becomes reticular over days
- clears in 3-10 days
- Bronchoscopy
- visualize potential causes/location
- rigid vs fiberoptic
- FOB identifies carcinoma in 2-13% pts with normal CXR
- timing
- Arteriography
- identify site
- therapeutic with embolization
- 80-90% initial control
- long term recurrence in 10-15%
- Radionuclide Scanning
- Chest Computed Tomography
Management
- Three Goals of Therapy
- prevent asphyxiation
- stop bleeding
- treat primary disease
- Airway Control
- supplemental oxygen
- positioning
- cough control
- endotracheal intubation a. selective intubation
- Volume Resuscitation
- Laboratory Evaluation
- hematocrit
- platelet count
- coagulation profile
- arterial blood gas, if appropriate
- renal function testing
- type and crossmatch blood
- smear, culture and cytology of sputum
- DLCO for pulmonary hemorrhage
Consultations
- Surgical
- Medical
- antibiotics if indicated
- medical management if nonlocalized bleeding, severely impaired pulmonary
function, disseminated terminal carcinoma, advanced bilateral pulmonary disease,
vasculitis
- Modalities
- bronchial artery embolization
- balloon tamponade
- intracavitary antifungal therapy
- Mortality
- medically managed patients with massive hemoptysis: 75%
- surgically managed patients with massive hemoptysis: 23%